ABSTRACT: Chemokines represent a major mediator of innate immunity and play a key role in the selective recruitment of cells during localized inflammatory responses. Beyond critical extracellular mediators of leukocyte trafficking, chemokines and their cognate receptors are expressed by a variety of resident and infiltrating cells (monocytes, lymphocytes, NK cells, mast cells, and NKT cells). Chemokines represent ideal candidates for mechanistic studies (particularly in murine models) to better understand the pathogenesis of chronic inflammation and possibly become biomarkers of disease. Nonetheless, therapeutic approaches targeting chemokines have led to unsatisfactory results in rheumatoid arthritis, while biologics against pro-inflammatory cytokines are being used worldwide with success. In this comprehensive review we will discuss the evidence supporting the involvement of chemokines and their specific receptors in mediating the effector cell response, utilizing the autoimmune/primary biliary cholangitis setting as a paradigm.

Chemokine and chemokine receptors in autoimmunity : the case of primary biliary cholangitis [Recensione] / J. Choi, C. Selmi, P.S.C. Leung, T.P. Kenny, T. Roskams, M.E. Gershwin. - In: EXPERT REVIEW OF CLINICAL IMMUNOLOGY. - ISSN 1744-666X. - 12:6(2016 Jun), pp. 661-672. [10.1586/1744666X.2016.1147956]

Chemokine and chemokine receptors in autoimmunity : the case of primary biliary cholangitis

C. Selmi
Secondo
;
2016

Abstract

ABSTRACT: Chemokines represent a major mediator of innate immunity and play a key role in the selective recruitment of cells during localized inflammatory responses. Beyond critical extracellular mediators of leukocyte trafficking, chemokines and their cognate receptors are expressed by a variety of resident and infiltrating cells (monocytes, lymphocytes, NK cells, mast cells, and NKT cells). Chemokines represent ideal candidates for mechanistic studies (particularly in murine models) to better understand the pathogenesis of chronic inflammation and possibly become biomarkers of disease. Nonetheless, therapeutic approaches targeting chemokines have led to unsatisfactory results in rheumatoid arthritis, while biologics against pro-inflammatory cytokines are being used worldwide with success. In this comprehensive review we will discuss the evidence supporting the involvement of chemokines and their specific receptors in mediating the effector cell response, utilizing the autoimmune/primary biliary cholangitis setting as a paradigm.
autoimmune cholangitis; biologics; chemokine receptor; Innate immunity; monoclonal antibody; tolerance breakdown; Immunology and Allergy; Immunology
Settore MED/16 - Reumatologia
Settore MED/09 - Medicina Interna
giu-2016
Article (author)
File in questo prodotto:
File Dimensione Formato  
2016-ERCI-chemokines galleys.pdf

Open Access dal 18/09/2017

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 562.03 kB
Formato Adobe PDF
562.03 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/424732
Citazioni
  • ???jsp.display-item.citation.pmc??? 20
  • Scopus 50
  • ???jsp.display-item.citation.isi??? 50
social impact